New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
11:54 EDTICPTIntercept rises 14% to $343.49 as trial link circulated
Shares of Intercept Pharmaceuticals (ICPT) are significantly higher in late morning trading, with the move up potentially related to the circulation of a link to data on a clinical trial being run by Intercept for its study to test Obeticholic Acid's effectiveness when used in patients with moderately severe alcoholic hepatitis. The trial was initially posted to the government's ClinicalTrials.gov website in January, though it is unclear if new data has been made available via the site or otherwise. Reference Link
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
17:05 EDTICPTOrbiMed reports 7% stake in Intercept
Subscribe for More Information
August 26, 2014
07:46 EDTICPTIntercept Pharmaceuticals volatility at low end of historic range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use